Intravenous Magnesium Sulfate As An Adjunct In The Treatment Of Severe Asthmatic Patients Non-Responding To Conventional Therapy
The Internet Journal of Asthma, Allergy and Immunology · 2002
DOI: 10.5580/2381 ↗At a glance
Journal article in The Internet Journal of Asthma, Allergy and Immunology, 2002. Cited 1 times so far (Crossref).
Abstract (original language)
Treatment of acute asthma is based on rapid reversal of bronchospasm and arresting airway inflammation. This study was done to determine the effect of intravenous MgSO4 for improvement of pulmonary fuction in patients with acute asthma non-responding to routine therapy. This randomized, double –blind controlled study was conducted on 48 patients, magnesium sulfate group , n=48 aged 12-85 years, 26 men, 22 women, and control (saline) group, n=33, aged 15-80 years, 17 men, 16 women, who had not responded to routine treatment. Peak expiratory flow rate (PEFR) was done before MgSO4 (25 mg/kg) and normal saline (100 ml) as a baseline criteria and after infusion of drugs at 30 mm and 3 hr. All patients were also given bronchodilators. The main outcome was PEER. Data were analyzed by X2 and t-test and differences between each point, were considered significant at P
Cite
APA
(2002). Intravenous Magnesium Sulfate As An Adjunct In The Treatment Of Severe Asthmatic Patients Non-Responding To Conventional Therapy. The Internet Journal of Asthma, Allergy and Immunology. https://doi.org/10.5580/2381
Vancouver
Intravenous Magnesium Sulfate As An Adjunct In The Treatment Of Severe Asthmatic Patients Non-Responding To Conventional Therapy. The Internet Journal of Asthma, Allergy and Immunology. 2002. doi:10.5580/2381
BibTeX
@article{euvimed2002,
title = {Intravenous Magnesium Sulfate As An Adjunct In The Treatment Of Severe Asthmatic Patients Non-Responding To Conventional Therapy},
journal = {The Internet Journal of Asthma, Allergy and Immunology},
year = {2002},
doi = {10.5580/2381}
}
EUVIMED